C

Cyclacel Pharmaceuticals
D

CYCC

1.44000
USD
-0.01
(-0.69%)
مغلق
حجم التداول
3,296
الربح لكل سهم
-1
العائد الربحي
-
P/E
1
حجم السوق
32,072,177
أصول ذات صلة
A
ARAY
-0.01000
(-0.63%)
1.57000 USD
A
AXSM
0.810
(0.78%)
104.990 USD
B
BCLI
-0.03500
(-3.15%)
1.07500 USD
C
CRBP
-0.15000
(-1.99%)
7.40000 USD
C
CYCCP
0.37000
(10.19%)
4.00000 USD
J
JAGX
-0.07000
(-1.55%)
4.45000 USD
K
KZIA
0.07000
(1.99%)
3.58000 USD
P
PAVM
-0.00610
(-0.94%)
0.64200 USD
V
VKTX
-0.715
(-2.58%)
26.985 USD
المزيد
الأخبار المقالات

العنوان: Cyclacel Pharmaceuticals Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.